Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Abscess × Adalimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 13 Spondylitis, Ankylosing 5 Colitis, Ulcerative 4 Psoriasis 3 Crohn Disease 3 Uveal Melanoma 1 Thyroid Carcinoma, Anaplastic 1 Spondylarthritis 1 Sarcoidosis 1 Recurrence 1 Plaque Psoriasis 1 Osteoarthritis 1 Nephrotic Syndrome 1 Nephrosis, Lipoid 1 Mucopolysaccharidosis VI 1 Mucopolysaccharidosis II 1 Mucopolysaccharidosis I 1 Mucopolysaccharidoses 1 Melanoma 1 Macular dystrophy, corneal type 1 1 Kidney Diseases 1 Joint Diseases 1 Inflammatory Bowel Diseases 1 Inflammation 1 Hidradenitis Suppurativa 1 Healthy Adult Male 1 Healthy 1 Glomerulosclerosis, Focal Segmental 1 Dupuytren Contracture 1 Autoimmune Diseases 1

Interventions

Sodium Chloride 1 Dexmedetomidine 1 Cefpirome 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01635764 2018-01-24

PIONEER (OLE)

AbbVie

Phase 3 Completed

508 enrolled 9 charts

Abscess, Acne Vulgaris, Hidradenitis Suppurativa

Data powered by HemOnc (CC BY 4.0) Colophon ⚡